Blog
RSS FeedPosted by Michael Wonder on 30 Nov 2020
Pharmacies add freezers, train staff to handle COVID-19 vaccination drive
29 November 2020 - Many supermarkets have offered customers flu shots for years, but COVID-19 vaccine distribution will require more coordination ...
Posted by Michael Wonder on 30 Nov 2020
Deploying big data to determine how well vaccines work
29 November 2020 - As the initial rollout starts, it’s time to start planning a registry to monitor health outcomes. ...
Posted by Michael Wonder on 29 Nov 2020
America will be the first country to roll out a COVID-19 vaccine
28 November 2020 - Here is how the federal government and states plan to do it. ...
Posted by Michael Wonder on 26 Nov 2020
After admitting mistake, AstraZeneca faces difficult questions about its vaccine
25 November 2020 - Some trial participants only got a partial dose of AstraZeneca’s vaccine. Experts said the company’s spotty disclosures ...
Posted by Michael Wonder on 25 Nov 2020
AstraZeneca gears up to vaccinate the world against COVID-19
24 November 2020 - Among the front-runners racing to deliver a COVID-19 shot, has the least vaccine experience. But it has ...
Posted by Michael Wonder on 25 Nov 2020
Third major COVID-19 vaccine shown to be effective and cheaper
24 November 2020 - Drugmaker AstraZeneca said late-stage trials showed its COVID-19 vaccine is highly effective, buoying the prospects of a ...
Posted by Michael Wonder on 25 Nov 2020
Pfizer vaccine distribution could kick off within weeks pending FDA approval, Azar says
24 November 2020 - A FDA panel will meet on 10 December to consider Pfizer’s emergency use authorisation application for its ...
Posted by Michael Wonder on 24 Nov 2020
Doctors say CDC should warn people the side effects from COVID vaccine shots won’t be ‘a walk in the park’
23 November 2020 - The CDC must be transparent about the side effects people may experience after getting their first shot ...
Posted by Michael Wonder on 24 Nov 2020
Success for a third—and perhaps most important—COVID-19 vaccine
23 November 2020 - The AstraZeneca-Oxford jab is likely to be widely used around the world. ...
Posted by Michael Wonder on 24 Nov 2020
Merck submits applications for licensure of V114, the company’s investigational 15 valent pneumococcal conjugate vaccine, for use in adults to the US FDA and EMA
23 November 2020 - Merck today announced the company has submitted applications to the US FDA and EMA for licensure of ...
Posted by Michael Wonder on 23 Nov 2020
COVID-19 shots could reach first Americans by mid-December, top health official says
23 November 2020 - U.S. health care workers and others recommended for the nation’s first COVID-19 inoculations could start getting shots ...
Posted by Michael Wonder on 23 Nov 2020
Politics, science and the remarkable race for a coronavirus vaccine
21 November 2020 - The furious race to develop a coronavirus vaccine played out against a presidential election, between a pharmaceutical ...
Posted by Michael Wonder on 21 Nov 2020
Pfizer and BioNTech to submit emergency use authorisation request today to the U.S. FDA for COVID-19 vaccine
20 November 2020 - In addition to today’s submission to the FDA, the companies have already initiated rolling submissions across the ...
Posted by Michael Wonder on 18 Nov 2020
Pfizer will seek regulatory review ‘within days’ for its vaccine
18 November 2020 - The coronavirus vaccine being developed by Pfizer and German biotechnology firm BioNTech is 95% effective at ...
Posted by Michael Wonder on 18 Nov 2020
The vaccines will probably work. Making them fast will be the hard part.
18 November 2020 - Front-runners in the coronavirus vaccine race won’t make nearly as many doses this year as were predicted, ...